Literature DB >> 19888958

Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer.

Z Cavdar1, A E Canda, C Terzi, S Sarioglu, M Fuzun, G Oktay.   

Abstract

AIM: The aim of this study was to evaluate the role of matrix metalloproteinases (MMPs), their tissue inhibitors [tissue inhibitors of metalloproteinases (TIMPs)] and activators [membrane-type MMPs (MT1-MMPs)], vascular endothelial growth factor (VEGF) and endostatin on clinicopathological variables and prognosis in patients with rectal cancer.
METHOD: Paired samples of tumour tissue and normal tissue were obtained from patients with rectal cancer who underwent curative surgery (n = 34). Gelatin zymography for MMP-2 and MMP-9, an activity assay for MT1-MMP and enzyme-linked immunoassays for TIMP-2, VEGF and endostatin were performed using extracts from the paired tissue samples.
RESULTS: Active MMP-9 showed statistically significant relationships with metastatic disease and perineural invasion (P = 0.002 and P = 0.042). A significant relationship was observed between the levels of tumoral pro-MMP-2 and pro-MMP-9 and the presence of lymph node metastasis (P = 0.012 and P = 0.021, respectively). Tumoral TIMP-2 levels showed a significant relationship with tumour recurrence (P = 0.011). A significant relationship was also observed between tumour VEGF levels and the presence of perineural invasion (P = 0.044), and VEGF levels were correlated with the size of the tumour (P = 0.009, r = 0.454).
CONCLUSION: These results might contribute to further investigation of a possible prognostic significance in rectal cancer.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19888958     DOI: 10.1111/j.1463-1318.2009.02105.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  ARK5 is associated with the invasive and metastatic potential of human breast cancer cells.

Authors:  Xin-Zhong Chang; Jie Yu; Hai-Yin Liu; Rui-Hua Dong; Xu-Chen Cao
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-22       Impact factor: 4.553

Review 2.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

3.  Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma.

Authors:  Lingyun Liu; Jian Wu; Yu Guo; Wenxuan Xie; Bin Chen; Yi Zhang; Shaoqiang Li; Yunpeng Hua; Baogang Peng; Shunli Shen
Journal:  Aging (Albany NY)       Date:  2018-12-21       Impact factor: 5.682

Review 4.  Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer.

Authors:  Cuong Cao Le; Amar Bennasroune; Benoit Langlois; Stéphanie Salesse; Camille Boulagnon-Rombi; Hamid Morjani; Stéphane Dedieu; Aline Appert-Collin
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

5.  Cinnamaldehyde Downregulation of Sept9 Inhibits Glioma Progression through Suppressing Hif-1α via the Pi3k/Akt Signaling Pathway.

Authors:  Zhiwen Wang; Changfeng Wang; Jieping Fu; Ruen Liu; Xinhui Zhou
Journal:  Dis Markers       Date:  2022-01-19       Impact factor: 3.434

Review 6.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

7.  Expression profiling using a cDNA array and immunohistochemistry for the extracellular matrix genes FN-1, ITGA-3, ITGB-5, MMP-2, and MMP-9 in colorectal carcinoma progression and dissemination.

Authors:  Suzana Angelica Silva Lustosa; Luciano de Souza Viana; Renato José Affonso; Sandra Regina Morini Silva; Marcos Vinicius Araujo Denadai; Silvia Regina Caminada de Toledo; Indhira Dias Oliveira; Delcio Matos
Journal:  ScientificWorldJournal       Date:  2014-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.